Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol

Fabry disease (FD) is a rare genetic disorder caused by a deficiency in the α-galactosidase A enzyme, which results in the globotriaosylceramide accumulation in many organs, including the kidneys. Nephropathy is a major FD complication that can progress to end-stage renal disease if not treated earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Battaglia, Yuri, Bulighin, Francesca, Zerbinati, Luigi, Vitturi, Nicola, Marchi, Giacomo, Carraro, Gianni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253838/
https://www.ncbi.nlm.nih.gov/pubmed/37297884
http://dx.doi.org/10.3390/jcm12113689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253838/
https://www.ncbi.nlm.nih.gov/pubmed/37297884
http://dx.doi.org/10.3390/jcm12113689

Ejemplares similares